OTC & PINK Stocks Mostly Higher (Primco Management Inc, Medisafe 1 Technologies Corp, Liquidmetal Technologies Inc, MultiCell Technologies)

Houston, TX -- (SBWIRE) -- 02/25/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.

Primco Management Inc (OTC:PMCM) jumped 14.58% and is trading at $0.0550. Primco Management Inc. is a development-stage company. The Company focuses on offering estate management services for its clients and retention on a range of properties including class A office space, industrial, manufacturing, and warehousing facilities as well as data centers and retail outlets for real estate users.

Can PMCM Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

Medisafe 1 Technologies Corp (OTC:MFTH) is higher 11.11% and is trading at $0.0030. Develops medical assemblies and protectors. The Company develops medications for medical errors and drug related injury.

How Should Investors Trade MFTH After The Recent Volatile Moves? Find Out Here

Liquidmetal Technologies Inc (OTC:LQMT) is lower 6.86% and is trading at $0.0950. Liquidmetal Technologies, Inc. (Liquidmetal Technologies) is materials technology company that develops and commercializes products made from amorphous alloys. The Company's Liquidmetal family of alloys consists of a variety of bulk alloys and composites that utilize the advantages offered by amorphous alloy technology.

Is LQMT Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here

MultiCell Technologies, Inc. (PINK:MCET) is higher 1.79% and is trading at $0.0057. MultiCell Technologies, Inc. (MultiCell), is a biopharmaceutical company. MultiCell is engaged developing therapeutics and discovery tools to address unmet medical needs for the treatment of neurological disorders, hepatic disease, cancer and interventional cardiology and peripheral vessel applications.

Can MCET Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

Disclaimer
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information
Winning Media LLC
1-800-411-7716
ir@AnotherWinningTrade.com